APA (7th ed.) Citation

Filion, K. B., Douros, A., Azoulay, L., Yin, H., Yu, O. H., & Suissa, S. (2019). Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study. British Journal of Clinical Pharmacology, 85(10), 2378. https://doi.org/10.1111/bcp.14056

Chicago Style (17th ed.) Citation

Filion, Kristian B., Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H. Yu, and Samy Suissa. "Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Adverse Cardiovascular Events: A Population‐based Cohort Study." British Journal of Clinical Pharmacology 85, no. 10 (2019): 2378. https://doi.org/10.1111/bcp.14056.

MLA (9th ed.) Citation

Filion, Kristian B., et al. "Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Adverse Cardiovascular Events: A Population‐based Cohort Study." British Journal of Clinical Pharmacology, vol. 85, no. 10, 2019, p. 2378, https://doi.org/10.1111/bcp.14056.